Menu
GeneBe

FKBP14

FKBP prolyl isomerase 14, the group of FKBP prolyl isomerases|EF-hand domain containing

Basic information

Region (hg38): 7:30010586-30026702

Links

ENSG00000106080NCBI:55033OMIM:614505HGNC:18625Uniprot:Q9NWM8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Definitive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Moderate), mode of inheritance: AR
  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ehlers-Danlos syndrome, kyphoscoliotic type, 2ARCardiovascularCardiovascular complications, including aortic rupture, have been described, and awareness and surveillance may allow rapid diagnosis and treatment, which may ameliorate morbidity and mortalityAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Genitourinary; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic22265013; 24773188

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FKBP14 gene.

  • Ehlers-Danlos syndrome, kyphoscoliotic and deafness type (146 variants)
  • Cardiovascular phenotype (58 variants)
  • not provided (38 variants)
  • Ehlers-Danlos syndrome (7 variants)
  • not specified (7 variants)
  • Inborn genetic diseases (7 variants)
  • Hypotonia (1 variants)
  • Joint hypermobility;Pes valgus;Thoracolumbar scoliosis;Hypotonia;Congenital muscular dystrophy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FKBP14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
37
clinvar
1
clinvar
38
missense
84
clinvar
1
clinvar
85
nonsense
2
clinvar
1
clinvar
2
clinvar
5
start loss
0
frameshift
3
clinvar
4
clinvar
7
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
3
splice region
3
8
11
non coding
23
clinvar
6
clinvar
29
Total 5 6 89 62 7

Highest pathogenic variant AF is 0.00000657

Variants in FKBP14

This is a list of pathogenic ClinVar variants found in the FKBP14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-30014063-G-A not specified Benign (Mar 29, 2016)402867
7-30014733-C-G Likely benign (Oct 21, 2020)1210573
7-30014735-C-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Pathogenic (Aug 07, 2019)807418
7-30014739-A-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (May 19, 2022)1904530
7-30014747-G-A Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Likely benign (Oct 13, 2021)1664557
7-30014752-T-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Cardiovascular phenotype Uncertain significance (Jan 25, 2023)947926
7-30014756-T-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Likely benign (Apr 02, 2023)2428030
7-30014776-T-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (Mar 18, 2022)645474
7-30014780-C-A Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Likely benign (Apr 12, 2022)2125023
7-30014782-C-T Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Cardiovascular phenotype Uncertain significance (Jan 04, 2023)2066341
7-30014789-G-A Cardiovascular phenotype Likely benign (Dec 08, 2023)3227107
7-30014789-G-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (May 24, 2019)945543
7-30014791-C-T Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (Nov 28, 2022)568303
7-30014795-A-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Likely benign (Dec 01, 2023)2882996
7-30014795-ATCT-A Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Pathogenic (Jan 15, 2019)599393
7-30014798-T-A Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Cardiovascular phenotype Uncertain significance (Jun 20, 2022)1422588
7-30014800-CTTT-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Ehlers-Danlos syndrome • Cardiovascular phenotype Conflicting classifications of pathogenicity (Jan 04, 2024)432050
7-30014801-T-C Cardiovascular phenotype Likely benign (Feb 28, 2023)3227106
7-30014803-T-A Uncertain significance (Jun 23, 2020)1302821
7-30014803-T-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (Aug 27, 2021)935725
7-30014810-A-T Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Cardiovascular phenotype Likely benign (Aug 02, 2021)1575555
7-30014811-A-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 • Cardiovascular phenotype Uncertain significance (May 11, 2023)1058327
7-30014813-A-G Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Likely benign (Aug 09, 2022)1647582
7-30014814-T-C Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (Nov 15, 2022)838953
7-30014815-C-A Ehlers-Danlos syndrome, kyphoscoliotic type, 2 Uncertain significance (Mar 29, 2021)1492987

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FKBP14protein_codingprotein_codingENST00000222803 416098
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000001520.24012560501431257480.000569
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.09391051080.9750.000004791404
Missense in Polyphen4046.8690.85344607
Synonymous0.7823339.20.8410.00000189371
Loss of Function0.070299.230.9754.60e-7122

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005460.000541
Ashkenazi Jewish0.000.00
East Asian0.0001650.000163
Finnish0.0002870.000277
European (Non-Finnish)0.001110.000985
Middle Eastern0.0001650.000163
South Asian0.0002410.000229
Other0.0004090.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: PPIase which accelerates the folding of proteins during protein synthesis. Has a preference for substrates containing 4- hydroxylproline modifications, including type III collagen. May also target type VI and type X collagens. {ECO:0000269|PubMed:24821723}.;
Disease
DISEASE: Ehlers-Danlos syndrome, kyphoscoliotic type, 2 (EDSKSCL2) [MIM:614557]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL2 is an autosomal recessive form characterized by severe generalized hypotonia at birth, myopathy, early-onset progressive kyphoscoliosis, joint hypermobility without contractures, hyperelastic skin with follicular hyperkeratosis, easy bruising, and occasional abnormal scarring, sensorineural hearing impairment, and normal pyridinoline excretion in urine. {ECO:0000269|PubMed:22265013}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
XBP1(S) activates chaperone genes (Consensus)

Recessive Scores

pRec
0.116

Intolerance Scores

loftool
0.751
rvis_EVS
-0.16
rvis_percentile_EVS
41.64

Haploinsufficiency Scores

pHI
0.171
hipred
N
hipred_score
0.389
ghis
0.561

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.949

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fkbp14
Phenotype

Gene ontology

Biological process
protein peptidyl-prolyl isomerization;IRE1-mediated unfolded protein response
Cellular component
endoplasmic reticulum lumen
Molecular function
peptidyl-prolyl cis-trans isomerase activity;calcium ion binding